Financials in USD. Standardized financial statements.
A compact view of how Innate Pharma S.A. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.79M | $12.62M | $61.64M | $49.64M | $12.11M | $69.77M | $68.97M | $79.89M | $32.63M | $56.16M |
| Revenue Growth? | -77.9% | -79.5% | +24.2% | +309.8% | -82.6% | +1.2% | -13.7% | +144.8% | -41.9% | 0.0% |
| Cost of Revenue? | $0 | $0 | $56.02M | $51.66M | $47.00M | $49.71M | $45.16M | $69.56M | $67.00M | $48.63M |
| Gross Profit? | $2.79M | $12.62M | $5.62M | $6.01M | -$22.30M | $20.07M | $23.82M | $10.34M | -$34.37M | $7.53M |
| Gross Margin? | +100.0% | +100.0% | +9.1% | +12.1% | -184.1% | +28.8% | +34.5% | +12.9% | -105.3% | +13.4% |
| Operating Expenses? | $56.21M | $64.20M | $18.29M | $63.44M | $25.52M | $18.99M | $50.87M | $74.75M | $72.61M | $48.59M |
| Operating Income? | -$53.42M | -$51.58M | -$12.67M | -$57.42M | -$47.83M | $1.08M | -$27.05M | $5.15M | -$39.98M | $7.57M |
| EBITDA? | -$43.65M | -$46.91M | -$7.58M | -$12.28M | -$43.23M | $13.30M | $18.11M | $12.48M | -$43.51M | $10.83M |
| Income Before Tax | -$49.18M | -$49.47M | -$7.57M | -$57.97M | -$45.48M | -$829,000 | -$20.76M | $2.72M | -$48.02M | $12.94M |
| Income Tax Expense | -$6.20M | $0 | $0 | $0 | $0 | $0 | $206,000 | -$333,000 | $368,000 | $301,000 |
| Net Income? | -$49.16M | -$49.47M | -$7.57M | -$58.10M | -$52.81M | -$63.98M | -$20.76M | $3.05M | -$48.38M | $12.64M |
| EPS? | $-0.55 | $-0.61 | $-0.09 | $-0.73 | $-0.57 | $-0.01 | $-0.31 | $0.05 | $-0.89 | $0.23 |
| Diluted EPS? | $-0.55 | $-0.61 | $-0.09 | $-0.73 | $-0.57 | $-0.01 | $-0.31 | $0.05 | $-0.89 | $0.23 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality